Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, safety, and tolerability of padsevonil in CYP2C19-genotyped healthy Japanese males
jRCT2080224874Phase 1Completed
- Sponsor
- UCB
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of padsevonil in epilepsy, sponsored by UCB. Primary endpoints: Pharmacokinetic profile of padsevonil, Safety of padsevonil and 1 more. Started Sep 2019; status: completed.
02
Drugs
padsevonil
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080224874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224874.